# Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

> **NCT06201416** · PHASE1 · RECRUITING · sponsor: **Sonoma Biotherapeutics, Inc.** · enrollment: 24 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** SBT777101

## Key facts

- **NCT ID:** NCT06201416
- **Lead sponsor:** Sonoma Biotherapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-06
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06201416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06201416, "Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06201416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*